Data Foundry

Drug recalls 2015

1% LIDOCAINE HCl Injection — Class I drug recall D-0382-2015

Terminated recall by Hospira Inc., reported 2015-02-11, distributed nationwide. Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, identified as

Recall numberD-0382-2015
Product typeDrug
ClassificationClass I
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmHospira Inc., Lake Forest, IL, United States
Recall initiated2014-04-18
Classified2015-01-30
Reported by FDA2015-02-11
Terminated2017-11-07
DistributedNationwide (US)
Quantity120,900 vials
Reason classesforeign material, specification failure
NDC00409-4275, 00409-4275-01, 00409-4275-16, 00409-4276, 00409-4276-01, 00409-4276-02, 00409-4276-16, 00409-4276-17, 00409-4277, 00409-4277-01, 00409-4277-02, 00409-4277-16, 00409-4277-17, 00409-4278, 00409-4278-01, 00409-4278-16, 00409-4279, 00409-4279-02, 00409-4279-16, 00409-4282, 00409-4282-01, 00409-4282-02, 00409-4282-11, 00409-4282-12, 00409-4282-25 and 14 more
Lot numbers31-427-DK
Expiration dates2015-07-01

Product

1% LIDOCAINE HCl Injection, USP, Preservative-Free, 10 mg/mL, 30 mL Single-dose vials, packaged in 25-count cartons, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-4279-02.

Reason for recall

Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, identified as iron oxide, were found embedded within the glass vial and floating in solution.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0382-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.